Erratum: Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP

更正：代谢体积是一个独立的预后因素，有助于识别接受 R-CHOP 方案治疗的弥漫性大B细胞淋巴瘤（DLBCL）患者的高危病例。